Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value ($000): $430,696 (100.0% shares, 0.0% debt)

Holdings (8)

AXGN AXOGEN INC 43.3%

Value ($000) $186,483 Shares 3,711,111 Est. Cost $4.01 Unrealized +999.8%

— REVANCE THERAPEUTICS INC 21.3%

Value ($000) $91,739 Shares 3,342,047 Est. Cost $31.50 Unrealized —

— CORIUM 17.4%

Value ($000) $74,920 Shares 9,353,304 Est. Cost $7.77 Unrealized —

— EYEPOINT 12.3%

Value ($000) $52,978 Shares 25,470,390 Est. Cost $1.79 Unrealized —

— ENDOLOGIX INC 3.2%

Value ($000) $13,623 Shares 1,257,468 Est. Cost $18.00 Unrealized —

MNOV MEDICINOVA INC 2.2%

Value ($000) $9,316 Shares 1,170,370 Est. Cost $2.95 Unrealized +250.5%

— CATALYST 0.2%

Value ($000) $933 Shares 78,622 Est. Cost $4.80 Unrealized —

ACUR ACURA PHARMACEUTICALS INC 0.2%

Value ($000) $704 Shares 1,956,397 Est. Cost $3.40 Unrealized -87.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
AXGN	AXOGEN INC	3,711,111	$186,483	43.3%	$4.01	+999.8%	COM	05463X106
—	REVANCE THERAPEUTICS INC	3,342,047	$91,739	21.3%	$31.50	—	COM	761330109
—	CORIUM	9,353,304	$74,920	17.4%	$7.77	—	COM	21887L107
—	EYEPOINT	25,470,390	$52,978	12.3%	$1.79	—	COM	74440J101
—	ENDOLOGIX INC	1,257,468	$13,623	3.2%	$18.00	—	COM	29266S106
MNOV	MEDICINOVA INC	1,170,370	$9,316	2.2%	$2.95	+250.5%	COM	58468P206
—	CATALYST	78,622	$933	0.2%	$4.80	—	COM	14888D109
ACUR	ACURA PHARMACEUTICALS INC	1,956,397	$704	0.2%	$3.40	-87.0%	COM	00509L802